(19)
(11) EP 2 381 954 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.01.2017 Bulletin 2017/04

(45) Mention of the grant of the patent:
02.11.2016 Bulletin 2016/44

(21) Application number: 10733840.2

(22) Date of filing: 21.01.2010
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
 C07K 14/00(2006.01)
(86) International application number:
PCT/US2010/021610
(87) International publication number:
WO 2010/085539 (29.07.2010 Gazette 2010/30)

(54)

METHODS AND COMPOSITIONS BASED ON SHIGA TOXIN TYPE 2 PROTEIN

VERFAHREN UND ZUSAMMENSETZUNGEN AUF DER BASIS VON SHIGATOXIN-TYP-2-PROTEIN

MÉTHODES ET COMPOSITIONS BASÉES SUR LA PROTÉINE SHIGA-TOXINE DE TYPE 2

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
AL BA RS

(30) Priority: 23.01.2009 US 146892 P
13.03.2009 US 210082 P

(43) Date of publication of application:
02.11.2011 Bulletin 2011/44

(73) Proprietor: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Bethesda, MD 20817 (US)

(72) Inventors:
  • O'BRIEN, Alison
    Bethesda, MD 20817 (US)
  • MELTON-CELSA, Angela
    Sterling, VA 20165 (US)
  • SMITH, Michael
    Silver Spring, MD 20904 (US)
  • SINCLAIR, James
    Baltimore, MD 21230 (US)

(74) Representative: Office Kirkpatrick 
Avenue Wolfers, 32
1310 La Hulpe
1310 La Hulpe (BE)


(56) References cited: : 
WO-A1-99/32645
WO-A1-2008/080218
WO-A2-2007/124133
CN-A- 101 314 616
US-A1- 2007 292 426
 WO-A1-2006/091677
WO-A2-2007/098201
WO-A2-2009/088403
US-A1- 2002 160 005
US-A1- 2008 107 653
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).